Remove 2003 Remove Intellectual Property Law Remove Patent Application Remove Registering Trademarks
article thumbnail

Understanding Freedom to Operate (FTO) Concerning IP & Patents

Kashishipr

Three pharmaceutical companies, including Enzon Pharmaceuticals, Micromet AG, and Cambridge Antibody Technology (now acquired by AstraZeneca), in September 2003 announced signing a non-exclusive cross-license agreement. However, in this case, it is imperative to note that determining the scope of a patent is not easy. Bottom Line.

IP 105
article thumbnail

Saving your Mark from Trademark Genericide

Kashishipr

Interestingly, in these cases, the trademark owner itself/himself misused the trademark as the generic name of the product in advertising and Patent Applications. ” For combating trademark genericide, conventional trademark enforcement measures have to be coupled with unconventional methods.

Trademark 105